Baidu
map
润色咨询

JOURNAL OF IMMUNOLOGY VIRUS-RESEARCH & EXPERIMENTAL CHEMOTHERAPY

出版年份：暂无数据 年文章数：0 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2093935, encodeId=dd7c209393586, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿2周，拒稿，理由是没有足够的评审！大家有遇到过这种理由拒稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Sat Oct 15 16:24:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227522, encodeId=2e3d122e522e3, content=这个杂志可以投综述吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf135430585, createdName=ms8000000588404152, createdTime=Mon Jun 20 11:30:24 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102140, encodeId=b5571102140d2, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102139, encodeId=c2f9110213966, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-10-15 shyhxyxz1005

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿2周，拒稿，理由是没有足够的评审！大家有遇到过这种理由拒稿的吗？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2093935, encodeId=dd7c209393586, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿2周，拒稿，理由是没有足够的评审！大家有遇到过这种理由拒稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Sat Oct 15 16:24:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227522, encodeId=2e3d122e522e3, content=这个杂志可以投综述吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf135430585, createdName=ms8000000588404152, createdTime=Mon Jun 20 11:30:24 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102140, encodeId=b5571102140d2, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102139, encodeId=c2f9110213966, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-06-20 ms8000000588404152

    这个杂志可以投综述吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2093935, encodeId=dd7c209393586, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿2周，拒稿，理由是没有足够的评审！大家有遇到过这种理由拒稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Sat Oct 15 16:24:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227522, encodeId=2e3d122e522e3, content=这个杂志可以投综述吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf135430585, createdName=ms8000000588404152, createdTime=Mon Jun 20 11:30:24 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102140, encodeId=b5571102140d2, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102139, encodeId=c2f9110213966, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-29 小动量

    SCI文章有哪些类型？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2093935, encodeId=dd7c209393586, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿2周，拒稿，理由是没有足够的评审！大家有遇到过这种理由拒稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Sat Oct 15 16:24:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227522, encodeId=2e3d122e522e3, content=这个杂志可以投综述吗？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf135430585, createdName=ms8000000588404152, createdTime=Mon Jun 20 11:30:24 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102140, encodeId=b5571102140d2, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102139, encodeId=c2f9110213966, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    什么是SCI？

    1

    展开1条回复
共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map